National Research Corporation (NRC) Revenue Growth
National Research Corporation (NRC) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 7.47% |
| 2018-12-31 | 1.81% |
| 2019-12-31 | 6.93% |
| 2020-12-31 | 4.14% |
| 2021-12-31 | 11.01% |
| 2022-12-31 | 2.44% |
| 2023-12-31 | -1.97% |
| 2024-12-31 | -3.72% |
| 2025-12-31 | -3.96% |
How NRC compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| PFE | Pfizer Inc. | -1.65% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
| QDEL | QuidelOrtho Corp Com | -1.89% |
| HAE | Haemonetics Corporation | -1.97% |
| VTRS | Viatris Inc. | -2.98% |
These are five companies in the same sector as NRC with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get National Research Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("NRC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NRC | $20.01 | -2.10% | 0.11M |
| 3 | ||||
| 4 | ||||
| 5 |